{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:37:08Z","timestamp":1789522628825,"version":"build-2803163510"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,8,1]]},"DOI":"10.2169\/internalmedicine.2879-23","type":"journal-article","created":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T17:14:25Z","timestamp":1702833265000},"page":"2215-2219","source":"Crossref","is-referenced-by-count":2,"title":["&lt;i&gt;LMNA::NTRK1&lt;\/i&gt; Fusion-positive Leiomyosarcoma: Discrepancy between DNA-based Comprehensive Genomic Profiling and RNA Sequencing"],"prefix":"10.2169","volume":"63","author":[{"given":"Norito","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Idogawa","sequence":"additional","affiliation":[{"name":"Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Emori","sequence":"additional","affiliation":[{"name":"Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Murase","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Arihara","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Usami","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Division of Clinical Cancer Genomics, Hokkaido University Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Sugita","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tokino","sequence":"additional","affiliation":[{"name":"Department of Medical Genome Sciences, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics and Genomics, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichi","family":"Takada","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sapporo Medical University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mosele F, Remon J, Mateo J, et al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann Oncol 31: 1491-1505, 2020.","DOI":"10.1016\/j.annonc.2020.07.014"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kikuchi J, Ohhara Y, Takada K, et al. Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan. Jpn J Clin Oncol 51: 753-761, 2021.","DOI":"10.1093\/jjco\/hyaa277"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Hagio K, Kikuchi J, Takada K, et al. Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers. Cancer Sci 114: 3385-3395, 2023.","DOI":"10.1111\/cas.15837"},{"key":"4","unstructured":"4. Doebele RC, Drilon A, Paz-Ares L, et al. Entrectinib in patients with advanced or metastatic <i>NTRK<\/i> fusion-positive solid tumours: integrated analysis of three phase 1-2 trials. Lancet Oncol 21: 271-282, 2020."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Drilon A, Laetsch TW, Kummar S, et al. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med 378: 731-739, 2018.","DOI":"10.1056\/NEJMoa1714448"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Solomon JP, Linkov I, Rosado A, et al. <i>NTRK<\/i> fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls. Mod Pathol 33: 38-46, 2020.","DOI":"10.1038\/s41379-019-0324-7"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Heydt C, Wolwer CB, Velazquez Camacho O, et al. Detection of gene fusions using targeted next-generation sequencing: a comparative evaluation. BMC Med Genomics 14: 62, 2021.","DOI":"10.1186\/s12920-021-00909-y"},{"key":"8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1186\/s12885-019-6114-2","volume":"19","author":"K Tanaka","year":"2019","unstructured":"8. Tanaka K, Mizusawa J, Naka N, et al. Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304. BMC Cancer 19: 890, 2019.","journal-title":"BMC Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2407","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1186\/s12864-018-5156-1","volume":"19","author":"TN Vu","year":"2018","unstructured":"9. Vu TN, Deng W, Trac QT, Calza S, Hwang W, Pawitan Y. A fast detection of fusion genes from paired-end RNA-seq data. BMC Genomics 19: 786, 2018.","journal-title":"BMC Genomics","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2164","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Wu S, Liu Y, Shi X, Zhou W, Zeng X. Elaboration of NTRK-rearranged colorectal cancer: integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant. Dig Liver Dis 2023.","DOI":"10.1016\/j.dld.2023.04.019"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Dufresne A, Pissaloux D, Ngo C, et al. Natural history and treatment efficacy in an ambispective case series of <i>NTRK<\/i>-rearranged mesenchymal tumors. ESMO Open 8: 101202, 2023.","DOI":"10.1016\/j.esmoop.2023.101202"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Br\u010di\u0107 I, Godschachner TM, Bergovec M, et al. Broadening the spectrum of <i>NTRK<\/i> rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of <i>NTRK<\/i> fusions. Mod Pathol 34: 396-407, 2021.","DOI":"10.1038\/s41379-020-00657-x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ida H, Koyama T, Mizuno T, et al. Clinical utility of comprehensive genomic profiling tests for advanced or metastatic solid tumor in clinical practice. Cancer Sci 113: 4300-4310, 2022.","DOI":"10.1111\/cas.15586"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Demetri GD, De Braud F, Drilon A, et al. Updated integrated analysis of the efficacy and safety of entrectinib in patients with <i>NTRK<\/i> fusion-positive solid tumors. Clin Cancer Res 28: 1302-1312, 2022.","DOI":"10.1158\/1078-0432.CCR-21-3597"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Hong DS, DuBois SG, Kummar S, et al. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials. Lancet Oncol 21: 531-540, 2020.","DOI":"10.1016\/S1470-2045(19)30856-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hibar DP, Demetri GD, Peters S, et al. Real-world survival outcomes in patients with locally advanced or metastatic <i>NTRK<\/i> fusion-positive solid tumors receiving standard-of-care therapies other than targeted TRK inhibitors. PLoS One 17: e0270571, 2022.","DOI":"10.1371\/journal.pone.0270571"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kage H, Shinozaki-Ushiku A, Ishigaki K, et al. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan. Cancer Sci 114: 1710-1717, 2023.","DOI":"10.1111\/cas.15717"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kohsaka S, Tatsuno K, Ueno T, et al. Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens. Cancer Sci 110: 1464-1479, 2019.","DOI":"10.1111\/cas.13968"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/15\/63_2879-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T23:42:21Z","timestamp":1722642141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/15\/63_2879-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":18,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2879-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,1]]},"article-number":"2879-23"}}